This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zaiss, A.-K.
Right arrow Articles by Chang, L.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zaiss, A.-K.
Right arrow Articles by Chang, L.-J.

 Previous Article  |  Next Article 

Journal of Virology, July 2002, p. 7209-7219, Vol. 76, No. 14
0022-538X/02/$04.00+0     DOI: 10.1128/JVI.76.14.7209-7219.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

RNA 3' Readthrough of Oncoretrovirus and Lentivirus: Implications for Vector Safety and Efficacy

Anne-Kathrin Zaiss, Sodany Son, and Lung-Ji Chang*

Department of Molecular Genetics and Microbiology, Powell Gene Therapy Center and McKnight Brain Institute, University of Florida, Gainesville, Florida 32610-0266

Received 11 December 2001/ Accepted 19 April 2002

The expression of reporter genes driven by the same human elongation factor 1{alpha} (EF1{alpha}) promoter in murine leukemia virus (MLV)- and human immunodeficiency virus type 1 (HIV-1)-based vectors was studied in either transfected or virally transduced cells. The HIV-1 vectors consistently expressed 3 to 10 times higher activity than the MLV vectors at both the RNA and protein levels. The difference was not attributable to transcriptional interference, alternative enhancer/silencer, or differential EF1{alpha} intron splicing. Based on nuclear run-on assays, both vectors exhibited similar EF1{alpha} transcriptional activity. The reduced RNA levels of MLV vectors could not be explained by the decrease in RNA half-lives. Southern analysis of proviral DNA indicated that both HIV-1 and MLV vectors efficiently propagated the EF1{alpha} intron in the transduced cells. To decipher the discrepancy in transgene expression between MLV and HIV-1 vectors, the role of RNA 3'-end processing was examined using a sensitive Cre/lox reporter assay. The results showed that MLV vectors, but not HIV-1 vectors, displayed high frequencies of readthrough of the 3' polyadenylation signal. Interestingly, the polyadenylation signal of a self-inactivating (SIN) HIV-1 vector was as leaky as that of the MLV vectors, suggesting a potential risk of oncogene activation by the lentiviral SIN vectors. Together, our results suggest that an efficient polyadenylation signal would improve both the efficacy and the safety of these vectors.


* Corresponding author. Mailing address: Rm. R1-252, ARB, Dept. of Molecular Genetics & Microbiology, University of Florida, Gainesville, FL 32610-0266. Phone: (352) 392-3315. Fax: (352) 392-5914. E-mail: lchang{at}mgm.ufl.edu.


Journal of Virology, July 2002, p. 7209-7219, Vol. 76, No. 14
0022-538X/02/$04.00+0     DOI: 10.1128/JVI.76.14.7209-7219.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Ramezani, A., Hawley, T. S., Hawley, R. G. (2008). Combinatorial Incorporation of Enhancer-Blocking Components of the Chicken {beta}-Globin 5'HS4 and Human T-Cell Receptor {alpha}/{delta} BEAD-1 Insulators in Self-Inactivating Retroviral Vectors Reduces Their Genotoxic Potential. Stem Cells 26: 3257-3266 [Abstract] [Full Text]  
  • Buffa, V., Negri, D. R. M., Leone, P., Bona, R., Borghi, M., Bacigalupo, I., Carlei, D., Sgadari, C., Ensoli, B., Cara, A. (2006). A single administration of lentiviral vectors expressing either full-length human immunodeficiency virus 1 (HIV-1)HXB2 Rev/Env or codon-optimized HIV-1JR-FL gp120 generates durable immune responses in mice. J. Gen. Virol. 87: 1625-1634 [Abstract] [Full Text]  
  • Oka, M., Rodic, N., Graddy, J., Chang, L.-J., Terada, N. (2006). CpG Sites Preferentially Methylated by Dnmt3a in Vivo. J. Biol. Chem. 281: 9901-9908 [Abstract] [Full Text]  
  • He, J., Yang, Q., Chang, L.-J. (2005). Dynamic DNA Methylation and Histone Modifications Contribute to Lentiviral Transgene Silencing in Murine Embryonic Carcinoma Cells. J. Virol. 79: 13497-13508 [Abstract] [Full Text]  
  • Hung, S.-C., Deng, W.-P., Yang, W. K., Liu, R.-S., Lee, C.-C., Su, T.-C., Lin, R.-J., Yang, D.-M., Chang, C.-W., Chen, W.-H., Wei, H.-J., Gelovani, J. G. (2005). Mesenchymal Stem Cell Targeting of Microscopic Tumors and Tumor Stroma Development Monitored by Noninvasive In vivo Positron Emission Tomography Imaging. Clin. Cancer Res. 11: 7749-7756 [Abstract] [Full Text]  
  • Baum, C., Dullmann, J., Li, Z., Fehse, B., Meyer, J., Williams, D. A., von Kalle, C. (2003). Side effects of retroviral gene transfer into hematopoietic stem cells. Blood 101: 2099-2113 [Abstract] [Full Text]